Minimal residual disease and survival outcomes in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis.

Chronic lymphocytic leukemia (CLL) patients who achieve undetectable minimal residual disease (U-MRD) (i.e.,

Source: Clinical Lymphoma, Myeloma and Leukemia - March 22, 2019 Category: Hematology Authors: Stefano Molica, Diana Giannarelli, Emili Montserrat Tags: Original Study Source Type: research